Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Cumberland Pharmaceuticals | 117.61 Mn | 113.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.74% |
| Mar 31, 2026 | -121.91% |
| Dec 31, 2025 | 27.38% |
| Sep 30, 2025 | -165.10% |
| Jun 30, 2025 | -158.90% |
| Mar 31, 2025 | 165.64% |
| Dec 31, 2024 | -23.73% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | 42.04% |
| Mar 31, 2024 | 69.81% |
| Dec 31, 2023 | -492.73% |
| Sep 30, 2023 | -223.32% |
| Jun 30, 2023 | 400.42% |
| Dec 31, 2021 | 1.31% |
| Sep 30, 2021 | -0.40% |
| Jun 30, 2021 | 0.69% |
| Mar 31, 2021 | -43.19% |
| Dec 31, 2020 | 12.10% |
| Sep 30, 2020 | 5.32% |
| Jun 30, 2020 | -9.73% |